口服治疗的强烈优化迅速恢复了恶化的心力衰竭患者的呼吸功能
Hajer Yaakoubi1, Lotfi Boukadida1, Marwa Toumia2
1Emergency Department of Sahloul, University of Sousse, Sousse, Tunisia.
ESC heart failure
|July 28, 2025
概括
在心力衰竭住院后,持续的呼吸困扰是常见的. 密集的随访和优化治疗显著改善呼吸并减少再入院,突出了综合SPO2和呼吸速率监测的需要.
科学领域:
- 心脏病学 心脏病学
- 肺部病理学 肺部病理学
- 临床研究 临床研究
背景情况:
- 气喘是脱补偿性心力衰竭 (HF) 的主要症状.
- 在因HF住院治疗后,持续性呼吸困难的患病率和进展情况尚不清楚.
研究的目的:
- 评估HF患者住院后持续呼吸困难的发生率.
- 为了确定与90天后呼吸系统恢复相关的因素.
- 评估90天和180天的再住院和死亡率.
主要方法:
- 针对急性呼吸障碍入院的HF患者进行前性多中心观察研究 (SIDI).
- 患者被跟踪了6个月.
- 主要终点:90日持续的呼吸困难;次要终点:90日和180日再住院/死亡. 对口服神经内分泌抑制的密集随访与标准护理进行了比较.
主要成果:
- 在第90天,69%的患者观察到持续的呼吸困难.
- 密集的随访显著改善了呼吸系统参数 (调整HR:5.70) 并减少了再住院/死亡.
- 没有发现呼吸恢复与性,糖尿病,高血压,脏疾病或NT-proBNP水平之间的联系.
结论:
- 在HF住院后的几个月里,持续的呼吸困扰是常见的.
- 优化的指导方针导向治疗和密切的随访可以促进呼吸系统的恢复.
- 建议将SpO2和呼吸速率监测整合到HF管理中.
相关概念视频
Acute Respiratory Failure-V
209
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
209
Heart Failure VI: Adjunct Therapies
28
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
28
COPD: Management Using Bronchodilators and Corticosteroids
314
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
314
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
319
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
319
Heart Failure V: Medical Management
25
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
25
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K


